Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus ErythematosusSkin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosusRecruitingPhase 32026-10-02NCT06617325

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
UCB Biopharma SRL30

242 results · Page 1 of 10

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Sl0044 20019GuangzhouChina1
Sl0044 20020ShanghaiChina1
Sl0044 20024NanjingChina1
Sl0044 20025WenzhouChina1
Sl0044 20030ChūōkuJapan1
Sl0044 20031SapporoJapan1
Sl0044 20032Suita-shiJapan1
Sl0044 20035Bunkyō CityJapan1
Sl0044 20039KawagoeJapan1
Sl0044 20042SaseboJapan1
Sl0044 20045Kita-gunJapan1
Sl0044 20065KitakyushuJapan1
Sl0044 20069Meguro-kuJapan1
Sl0044 20070Shinjuku-kuJapan1
Sl0044 20071NagasakiJapan1
Sl0044 20076Shinjuku-kuJapan1
Sl0044 20080TaichungTaiwan1
Sl0044 20082TaiyuanTaiwan1
Sl0044 20084SagaJapan1
Sl0044 20086TaipeiTaiwan1
Sl0044 20092SuwonSouth Korea1
Sl0044 20099TaipeiTaiwan1
Sl0044 20104SeoulSouth Korea1
Sl0044 20105SeoulSouth Korea1
Sl0044 20108IncheonSouth Korea1